No cardiac safety concerns reported with a pharmaceutically manufactured cannabidiol formulation

by

A pharmaceutically produced cannabidiol formulation had a good overall safety profile, including cardiac safety, according to research presented at Heart Failure 2025.

Leave A Comment

Your email address will not be published. Required fields are marked *